Literature DB >> 3619222

The antihypertensive effect of verapamil at extremes of dietary sodium intake.

J P Nicholson, L M Resnick, J H Laragh.   

Abstract

Restricting sodium intake is a primary recommendation for patients with hypertension, including those receiving drug treatment. Few studies, however, have examined the impact of different levels of sodium intake on the effectiveness of antihypertensive drugs. We administered two courses of verapamil to 13 patients with essential hypertension during a low-sodium (NaCl, 9 meq/d) and high-sodium (212 meq/d) diet. Overall, verapamil was an effective antihypertensive agent, but expressed its greatest potency in the lower-renin, sodium-sensitive subgroup. Moreover, the antihypertensive efficacy of verapamil was not blunted by the high-sodium intake (change in systolic/diastolic blood pressure, 18.8/17.7 in sodium sensitive patients compared with -11.4/-8.7 in sodium insensitive patients; p less than 0.05). Thus, dietary sodium restriction may not be necessary or appropriate in the treatment of essential hypertension with verapamil; salt-induced cellular calcium uptake may be involved in the phenomenon of sodium sensitivity.

Entities:  

Mesh:

Substances:

Year:  1987        PMID: 3619222     DOI: 10.7326/0003-4819-107-2-329

Source DB:  PubMed          Journal:  Ann Intern Med        ISSN: 0003-4819            Impact factor:   25.391


  10 in total

Review 1.  Is salt restriction necessary in hypertensive patients treated with calcium antagonists?

Authors:  J Redon
Journal:  Drugs       Date:  1992       Impact factor: 9.546

Review 2.  Renal effects of calcium entry blockers.

Authors:  L M Ruilope; J M Alcazar
Journal:  Cardiovasc Drugs Ther       Date:  1990-08       Impact factor: 3.727

Review 3.  Verapamil. An updated review of its pharmacodynamic and pharmacokinetic properties, and therapeutic use in hypertension.

Authors:  D McTavish; E M Sorkin
Journal:  Drugs       Date:  1989-07       Impact factor: 9.546

Review 4.  Diuretics and cation transport in hypertensive blacks.

Authors:  A P Quintanilla; O E Wagener
Journal:  Cardiovasc Drugs Ther       Date:  1990-03       Impact factor: 3.727

Review 5.  Cardiovascular drug therapy in the elderly: theoretical and practical considerations.

Authors:  Bradley R Williams; Jiwon Kim
Journal:  Drugs Aging       Date:  2003       Impact factor: 3.923

Review 6.  Has the role of calcium channel blockers in treating hypertension finally been defined?

Authors:  George S Chrysant; Steven G Chrysant
Journal:  Curr Hypertens Rep       Date:  2003-08       Impact factor: 5.369

7.  Obesity as a determinant for response to antihypertensive treatment.

Authors:  R E Schmieder; C Gatzka; H Schächinger; H Schobel; H Rüddel
Journal:  BMJ       Date:  1993-08-28

8.  Sodium intake does not influence the effect of verapamil in hypertensive patients with mild renal insufficiency.

Authors:  L M Ruilope; M C Casal; L Guerrero; J M Alcázar; M L Férnandez; V Lahera; J L Rodicio
Journal:  Drugs       Date:  1992       Impact factor: 9.546

Review 9.  The efficacy of beta-adrenoceptor and calcium-entry blockers in hypertensive blacks.

Authors:  J R M'Buyamba-Kabangu; M Tambwe
Journal:  Cardiovasc Drugs Ther       Date:  1990-03       Impact factor: 3.727

Review 10.  Current drug treatment and treatment patterns with antihypertensive drugs.

Authors:  E D Freis; V Papademetriou
Journal:  Drugs       Date:  1996-07       Impact factor: 9.546

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.